Beta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure

BMC Cardiovascular Disorders

Volumn 9, Issue , 2009, Pages 50-

  Mansur, Alfredo J ^a   Fontes, Rosana S ^a   Canzi, Regina A ^a   Nishimura, Raphael ^a   Alencar, Airlane P ^a   de Lima, Antonio C P ^a   Krieger, José E ^a   Pereira, Alexandre C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLUTAMIC ACID; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; PROLACTIN; SPIRONOLACTONE; TRIACYLGLYCEROL; VASODILATOR AGENT; WARFARIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEART FAILURE; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 70749153558     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-9-50     Document Type: Article

References (19)

1. Donahue MP, Marchuk DA, Rockman HA. Redefining heart failure: the utility of genomics. J Am Coll Cardiol 2006, 48(7):1289-1298. 10.1016/j.jacc.2006.05.062, 17010784.
2. Liggett SB, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC, Walsh RA. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998, 102(8):1534-1539. 509003, 9788966, 10.1172/JCI4059.
3. Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, Abraham WT, Chenier TC, Dorn GW, Liggett SB. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 2000, 86(8):834-840.
4. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 285(26):1441-1446.
5. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996, 93(5):841-842.
6. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980, 44(6):672-673. 482464, 7459150, 10.1136/hrt.44.6.672.
7. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, 46(6):e1-82. 10.1016/j.jacc.2005.08.022, 16168273.
8. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, Arner P. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997, 100(12):3005-3013. 508512, 9399946, 10.1172/JCI119854.
9. Pereira AC, Floriano MS, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, Krieger JE. Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 2003, 42(4):685-692. 10.1161/01.HYP.0000085648.65419.17, 12900437.
10. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005, 112(12):1756-1762. 10.1161/CIRCULATIONAHA.104.530972, 16157772.
11. de Freitas HF, de Castro PP, Chizzola PR, Bocchi EA. [Heart transplantation in a patient with endomyocardial fibrosis]. Arq Bras Cardiol 2005, 84(1):49-50.
12. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006, 113(11):1424-1433. 10.1161/CIRCULATIONAHA.105.584102, 16534009.
13. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003, 107(2):223-225. 10.1161/01.CIR.0000052622.51963.FC, 12538418.
14. de Groote P, Lamblin N, Helbecque N, Mouquet F, Hermant X, Amouyel P, Dallongeville J, Bauters C. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients. Am Heart J 2006, 152(4):736-741. 10.1016/j.ahj.2006.04.003, 16996850.
15. Forleo C, Resta N, Sorrentino S, Guida P, Manghisi A, De Luca V, Romito R, Iacoviello M, De Tommasi E, Troisi F. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. Am J Med 2004, 117(7):451-458. 10.1016/j.amjmed.2004.04.012, 15464701.
16. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 2005, 294(12):1526-1533. 10.1001/jama.294.12.1526, 16189366.
17. Shin J, Lobmeyer MT, Gong Y, Zineh I, Langaee TY, Yarandi H, Schofield RS, Aranda JM, Hill JA, Pauly DF. Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure. Am J Cardiol 2007, 99(2):250-255. 10.1016/j.amjcard.2006.08.020, 17223428.
18. Heckbert SR, Hindorff LA, Edwards KL, Psaty BM, Lumley T, Siscovick DS, Tang Z, Durda JP, Kronmal RA, Tracy RP. Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003, 107(15):2021-2024. 10.1161/01.CIR.0000065231.07729.92, 12682000.
19. Kaye DM, Smirk B, Williams C, Jennings G, Esler M, Holst D. Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics 2003, 13(7):379-382. 10.1097/00008571-200307000-00002, 12835612.